InMed Pharmaceuticals Inc.
Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.
INM | NDAQ
Overview
Corporate Details
- ISIN(s):
- CA4576375022
- LEI:
- Country:
- United States of America
- Address:
- 1445-885 WEST GEORGIA ST., VANCOUVER
- Website:
- https://www.inmedpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on developing a proprietary pipeline of small molecule drug candidates targeting the CB1 and CB2 receptors. The company's main therapeutic programs address significant unmet medical needs, including preclinical candidates for Alzheimer’s disease (INM-901) and dry age-related macular degeneration (INM-089), as well as a completed Phase 2 clinical trial for epidermolysis bullosa. Additionally, through its subsidiary BayMedica, InMed manufactures and supplies high-purity, bioidentical rare cannabinoids (including CBC, d9-THCV, CBDV, and CBTC) as raw ingredients for the B2B health and wellness product market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all InMed Pharmaceuticals Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for InMed Pharmaceuticals Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for InMed Pharmaceuticals Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
